ZURA

Conviction 47HealthcareScan · Thu, Sep 24, 2026

Hammer

Zura Bio Ltd (ZURA) closed at $4.15 (-4.16%) on Sep 24, 2026. Its latest daily candle is a hammer. Price is below its 50-day and below its 200-day moving average. RSI(14) 27, RS Rating 95, -41.0% from its 52-week high, -25.2% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

ZURA$4.15-4.16%

ResistanceSupportVol 14

Vol MA14 1.91M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Zura Bio LtdBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.zurabio.com ↗

Price4.15

Change-4.16%

Gap-0.69%

Rel volume3.75×

Avg volume1.75M

Avg $ vol8.8M

SMA 205.21

SMA 505.46

SMA 2005.32

Price vs 50-24.05%

Price vs 200-21.94%

MA stackmixed

50/200 cross—

Supertrenddown · 5.13

RSI (14)27

MACD hist-0.14

MACD cross—

Stoch %K / %D13 / 9

ADX (14)26

+DI / −DI13 / 35

RSI divergence—

MACD divergence—

ATR %8.65%

ADR %6.74%

52w high7.04

52w low2.10

From 52w high-41.05%

Above 52w low+97.62%

New 52w highNo

SqueezeOff

Bollinger width48.84%

%B0.08

Donchian pos12.63%

Donchian high6.26

Donchian low3.85

AVWAP (52w high)5.17

vs AVWAP high-19.67%

AVWAP (52w low)4.73

vs AVWAP low-12.25%

OBV trendDown

Chaikin MF (20)-0.07

Today vs 20d3.75×

Avg vol (14d)1.91M

Avg vol (20d)1.75M

Avg $ vol (20d)8.8M

Market cap397.69M

RS Rating95 / 99

RS 3m (vs SPY)-13.08%

RS 6m (vs SPY)-42.97%

RS line new highNo

Trend template4/8

Technical rank10.1

1 week-9.19%

1 month-34.34%

3 months-8.59%

6 months-26.16%

1 year+101.46%

YTD-25.23%

P/E-5.79

P/B3.92

P/S—

P/FCF-6.13

EPS-1.06

Div yield—

ROE-67.61%

ROA-32.17%

Debt/Eq—

Current12.90

EV/EBITDA-2.56

Gross margin—

Net margin—

Rev growth—

EPS growth-31.00%

Price target22.67

Target upside446.27%

Analyst ratingBuy

Institutional76.26%

Ent. value192.56M

Revenue—

Net income-26.3M

Gross profit—

Free cash flow-64.93M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out95M

Employees40

ListedTue, Mar 21, 2023

Free float52.02M

Float %54.8%

Short interest11.1M

Days to cover5.8d

Short volume48.2%

Squeeze score85 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.21 vs −$0.20

Last surprise-5.0% miss

Setup gradeC

Conviction47 / 100

Pattern quality—

Tech rank10.1 / 100

Group rank59 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmHammer

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ZURA

All disclosures →

No recent disclosed trades by Congress in ZURA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ZURA

Insider	Side	Shares	Value	Traded	Filed
Thiara Parvinder Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Schoch Steven J Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Nirula Ajay Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Eisner Mark Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Jarrett Jennifer Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Munshi Amit Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Becker Daniel J. Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22

SEC filings

EDGAR filings in ZURA · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.